Literature DB >> 8931721

Antibiotic GE37468A: a new inhibitor of bacterial protein synthesis. III. Strain and fermentation study.

F Marinelli1, L Gastaldo, G Toppo, C Quarta.   

Abstract

GE37468A is a new thiazolyl peptide antibiotic acting on Elongation Factor Tu, produced by fermentation of Streptomyces sp. ATCC 55365. The low (< 10 mg/liter) and poorly reproducible antibiotic productivity of the original soil isolate hampered the development of a scalable fermentation process. A tenfold increase of GE37468A productivity was achieved by selection of spontaneous morphochromatic variants, which appeared at high frequency in the wild type population. The higher producing ATCC 55365/O/5 colony was tyrosinase defective and blocked in the aerial mycelium differentiation (Amy-Mel- phenotype). The fermentation process of this stable and purified strain was rapidly optimized to achieve a further fourfold improvement in a fed-batch process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931721     DOI: 10.7164/antibiotics.49.880

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Identification of the thiazolyl peptide GE37468 gene cluster from Streptomyces ATCC 55365 and heterologous expression in Streptomyces lividans.

Authors:  Travis S Young; Christopher T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

2.  Codon randomization for rapid exploration of chemical space in thiopeptide antibiotic variants.

Authors:  Travis S Young; Pieter C Dorrestein; Christopher T Walsh
Journal:  Chem Biol       Date:  2012-12-21

3.  Sponge-derived Kocuria and Micrococcus spp. as sources of the new thiazolyl peptide antibiotic kocurin.

Authors:  Sara Palomo; Ignacio González; Mercedes de la Cruz; Jesús Martín; José Rubén Tormo; Matthew Anderson; Russell T Hill; Francisca Vicente; Fernando Reyes; Olga Genilloud
Journal:  Mar Drugs       Date:  2013-03-28       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.